Angiogenic Switch as Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer
Latest Information Update: 03 Mar 2017
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 02 Aug 2016 New trial record
- 07 Jun 2016 Status changed from active, no longer recruiting to completed, according to results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology